chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About one week after vaccine I had joint pain and rash on hands and feet. Very Itchy rash. I went to see my doctor and he gave me steroid cream for rash. The cream helped and the rash disappeared after five days . The joint pain went away with onset of rash. Second dose received no rash just fever and chills for one day.
Injection site soreness for 3 days post injection which started about 8 hours after the injection.  Under arm axillary swelling and pain which started about 2 days after the first vaccine dose and lasted about 10 days as the pain dissipated gradually over these days.  After the axillary pain disappeared, Lt medial epicondyle sensitivity began along with burning and tingling skin sensitivity started on the ulnar side of the injected arm which has continued as of this date.  Burning sensation on and off on the side of injected arm thenar eminence starting 3 days post first vaccination.
Initial report received on 12 October 2007 from a health care professional. A 60-year-old female patient, who had recently stepped on a nail, had received a right gluteal, intramuscular injection of Decavac, lot number U1820GA, on 08 October 2007. The next day, the patient developed a swollen tongue and soreness under the left side of her tongue. She experienced no shortness of breath or wheezing, and her speech was clear. The following day, she was examined in an emergency room and treated with intravenous Benadryl and "intravenous" epinephrine. The patient also took oral Benadryl daily. Per the reporter, the soreness and some swelling persists. At the time of this report, the patient had not recovered.
mom describes DTP site large hardened, raised reddened area from shoulder to half-way to elbow; seen by MD on 9MAR96;mom was told pt having allergic rx to DTP & should not be given again;10MAR seen again w/fine rash on thigh, face;
Greater than 28 days since first dose,She still has not received the second dose, she is waiting to get it.; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Greater than 28 days since first dose,She still has not received the second dose, she is waiting to get it.) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 10-Dec-2021.    In February 2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Greater than 28 days since first dose,She still has not received the second dose, she is waiting to get it.). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Greater than 28 days since first dose,She still has not received the second dose, she is waiting to get it.) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant products were reported.  Patient received their first dose of the vaccine in February 2022. She still has not received the second dose, she is waiting to get it.  No treatment drugs were reported.
vaccine given to 27 weeks pregnant patient with no reported adverse event; Initial information received on 01-May-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 21 years old female patient who was exposed to vaccine influenza usp trival a-b subvirion no preservative vaccine [fluzone] in context of vaccine given to 27 weeks pregnant patient with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known.   The reported vaccine given to 27 weeks pregnant patient with no reported adverse event occurred at 27 weeks of pregnancy and the patient was exposed to Influenza usp trival a-b subvirion no preservative vaccine at 27 weeks of pregnancy, during third pregnancy trimester for influenza usp trival a-b subvirion no preservative vaccine. The date of last menstrual period was reported as 23-Oct-2022. The estimated due date is 30-Jul-2023. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies.   On 28-Apr-2023, the patient received 0.5 ml of suspect influenza usp trival a-b subvirion no preservative vaccine Suspension for injection lot UJ906AA, 30-Jun-2023 via intramuscular route in the left deltoid for Influenza.  On 28-Apr-2023 the patient developed a non-serious vaccine given to 27 weeks pregnant patient with no reported adverse event (exposure during pregnancy) (latency: same day).  Relevant prenatal testing after exposure was unknown  Lab data was not reported.  Action taken was not applicable.  Outcome: Unknown for the event vaccine given to 27 weeks pregnant patient with no reported adverse event. Additionally, at time of reporting, the pregnancy is still ongoing.
Information has been received from a county health registered nurse concerning an 8 year old male who on 29-JUL-1999 was vaccinated with VARIVAX (Oka/Merck).  On 08-APR-2007 the patient developed varicella < 50 lesions.  The nurse reported that an outbreak of varicella had taken place in the local school district in April 2007, and this student was identified during the county health investigation.  An immunization clinic was conducted in the school where students received a second dose of VARIVAX (Oka/Merck).  This is one of 28 reports received from the same source.  No further information is available.
Rheumatoid arthritis flare up; This spontaneous case was reported by a consumer and describes the occurrence of RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis.   On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Aug-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In August 2021, the patient experienced RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) (seriousness criterion medically significant). At the time of the report, RHEUMATOID ARTHRITIS (Rheumatoid arthritis flare up) had resolved.            Concomitant medication was not provided.  Treatment medication information was not provided by the reporter.  In Aug-2021, patient experienced Rheumatoid arthritis flare up on whole body. It was unknown if patient was enrolled in COVID-19 vaccine trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna  were missed to be booked-in.  Company comment: This spontaneous case concerns a 71 year old female patient, with concurrent condition of rheumatoid arthritis, who experienced the unexpected serious (medically significant) of Rheumatoid arthritis (reported as Rheumatoid arthritis flare up), unknown days after receiving a dose (dosing number unclear) of mRNA-1273 vaccine in the COVID-19 vaccination series. The event resolved. No information on exact date of the event, detailed clinical course and relevant investigations was available in the report. Concurrent condition of rheumatoid arthritis could be confounding for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.   This case was linked to MOD-2022-624812 (Patient Link).; Sender's Comments: This spontaneous case concerns a 71 year old female patient, with concurrent condition of rheumatoid arthritis, who experienced the unexpected serious (medically significant) of Rheumatoid arthritis (reported as Rheumatoid arthritis flare up), unknown days after receiving a dose (dosing number unclear) of mRNA-1273 vaccine in the COVID-19 vaccination series. The event resolved. No information on exact date of the event, detailed clinical course and relevant investigations was available in the report. Concurrent condition of rheumatoid arthritis could be confounding for the event. The benefit-risk relationship of mRNA-1273 is not affected by this report.
See attached dictation - 04/30/04 - Local reaction.  05/20/04: Vesicular rash at injection site, viral studies done: negative.  The pt is a 5 year old white male with history as above. Basically, he has had some erythema and swelling at the injection site from a recent immunization done 3 days ago. Prescribed: Empiric therapy with Keflex 250mg per mouth three times a day for 7 days. Atarax 10-20 mg per mouth twice daily as needed. Return or call back if symptoms worsen or persist and this was discussed.
Chills; Headache; soreness in injection arm and pectoral muscle; soreness in injection arm and pectoral muscle; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Apr-2021 and was forwarded to Moderna on 09-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in injection arm and pectoral muscle), CHEST PAIN (soreness in injection arm and pectoral muscle), CHILLS (Chills) and HEADACHE (Headache) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026b21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (soreness in injection arm and pectoral muscle) and CHEST PAIN (soreness in injection arm and pectoral muscle). On 03-Apr-2021, the patient experienced CHILLS (Chills) and HEADACHE (Headache). On 03-Apr-2021, PAIN IN EXTREMITY (soreness in injection arm and pectoral muscle) and CHEST PAIN (soreness in injection arm and pectoral muscle) had resolved. On 04-Apr-2021, CHILLS (Chills) and HEADACHE (Headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided
A report has been received from a health professional concerning a 1  year old, female subject, who had been receiving FLUMIST Quadrivalent. FLUMIST Quadrivalent started on an unknown date. It was reported  that a patient was inadvertently administered FLUMIST Quadrivalent to a 18 month old child. The outcome of the event of Administered FLUMIST Quadrivalent to an 18 month old is unknown. The report was considered to be non-serious.
about 1.5 days after receiving vaccine, developed severe stomach pains and a migraine with neck pain. went to the emergency room and was prescribed medication. symptoms resolved after 4 days.
Itching, tingling of effected areas--right torso. Began spraying with Bactine to desensitize best possible.
This spontaneous report was received from a pharmacist and refers to a multiple unspecified patient of unknown age and gender. The patients' medical history and concurrent conditions were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of ZOSTAVAX (lot # L037790, expiry date: 30-DEC-2016, route of administration was not reported). Concomitant therapy was not reported. Reported temperature excursion was 10F for 48 hours. Data logger was involved. There was no previous temperature excursion. No adverse effect was reported. Additional information has been requested.
Mild injection site pain began 7 days post vaccination, tenderness increased slightly on day 8, and on day 9 redness has appeared at injection site. Arm feels slightly weak and skin burns slightly (similar to nerve pain). No itching.
The symptoms began on Sunday 5/8/2022 with a dry cough. I thought it was seasonal allergies but it persisted. On Monday 5/9/2022, I started to get congested and thought it was still allergies. Tuesday morning, I wasn't feeling right and decided to do an at-home test and it was positive. I scheduled a rapid test at a local pharmacy, and they did that test and it came back positive as well. At that point, I contacted my doctor to talk to them and had a telehealth visit and had a visit with Dr.  yesterday and discussed the symptoms and my age. They recommended I get monoclonal antibody infusion which is scheduled for later today. Haven't recovered yet but improving.
Fever, Tachycardia, CHILLS Narrative: PULSE WAS 115 FOR ABOUT 3 HOURS. TOOK TYLENOL AND NO FEVER, CHILLS OR HIGH PULSE NEXT MORNING
Itching, eyes swelling immediately after vaccine administration that did not resolve with Benadryl, and BP 140/90,  patient was later taken away by EMS
Redness, swelling, and soreness noted at injection site noming after receiving vaccine. Cool compress applied to site. Ibuprofen given. Symptoms relieved.
Provider d/c note:  "Patient is a pleasant 83 YO  female who presented 9/30/2022  9:44 AM to inpatient rehab after primary admission to hospital for profound weakness due to covid 19.  She says she began to notice symptoms on the evening of Sept 22 with stuffy nose that proceeded to a productive cough.  Her husband had covid and she tested + at home on Sept. 23.  By the next day she was profoundly weak and needed help getting around whereby she was able to do things independently with a walker previously.   She has a hx of malignant melanoma with mets to the brain diagnosed in April 2022.  She will have f/u MRI and CT scans as an ouptatinet in approx 3 weeks.   She says she has begun to recover physically from the covid and is nearly back to the strength and function she had on discharge from inpatient rehab on her previous visit.  She did however have trouble completing therapy at hospital due to fatigue.  She says her cough improves daily and is down to only about 6 coughs / day."
Presented to hospital w/ sob; dx'd with pneumonia, unspecified organism; respiratory failure, unspecified with hypoxia. HPI: hx of severe COPD and emphysema that is on 4 L of O2 at home; recent positive COVID test; allergic to codeine, penicillins, vancomycin; current some day smoker Treatment: pt treated with lorazepam, dexamethasone, zithromax, rocephin chest xray 09/08/21 findings consistent with bilateral multifocal pneumonia and small left pleural effusion
First day there was a red line going under the site an hour after injection. 2-4 th day there was bruising, swelling, warm to the touch, and a red area underneath the injection site. Visited a MD (seeked out help after results worsening) and he stated it was due to a vessel being punctured  during  injection (not due to vaccine) which caused the bruising  at the site and the redness/swelling is due to the vaccine.  It?s on day four now and the bruising is healing but the redness and swelling is still consistent. MD cleared me of no infection but stated if redness grows (or fevers) to seek out help again.
My father had a massive stroke and brain hemorrhage that took his life.; My father had a massive stroke and brain hemorrhage that took his life.; This is a spontaneous report from a contactable consumer. A 65-year-old male patient (reporter's father) received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration at the age of 65-years-old on 15Mar2021 12:00 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient's medical history was not reported. No known allergies. Not diagnosed with COVID prior vaccination. There were no concomitant medications. No other vaccines in four weeks. No other medications in two weeks. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The reporter stated that, "My father had a massive stroke and brain hemorrhage that took his life" on 15Apr2021 09:30 PM. No treatment received for the events. The events resulted in Emergency room/department or urgent care. The patient died on 18Apr2021. It was not reported if an autopsy was performed. Unknown if tested for COVID post vaccination.  Information about lot/batch number has been requested.; Reported Cause(s) of Death: My father had a massive stroke and brain hemorrhage that took his life.; My father had a massive stroke and brain hemorrhage that took his life.
The mother of the patient states immediately after injection patient fell to the floor and seized. The seizure was not timed. The mother noticed a gagging noise, fine red rash on the chest, neck, and face which resolved within 5-10 minutes after onset. The mother also noticed whites of the eyes were pink. On 05/22/00, the patient went to Allergy, Asthma & Associates re: reaction to Hepatitis B vaccine.  They are a reporting agent, they did not administer the vaccine.
Patient received PREVNAR 13 vaccine in left arm on 09/17/2015. She now complains that she is having pain from this arm. When vaccine serum was injected she immediately felt tingling down her arm. This numbness/tingling (down to pinky finger) would come and go for 3 days, then stopped. She now experiences extreme pain with movement of the arm. She went to the doctor whom did an x-ray which did not lead to a diagnosis. Doctor prescribed her clindamycin for 10 days thinking she might have an abscess. She also wore a sling for a couple days to limit movement of the arm. Pain is still not resolved. Patient stated that while in doctor's office she had to take left across body to touch right shoulder and the pain was so bad she was about to cry. Patient does not feel this was a reaction to the vaccine. She previously received Flu and ZOSTAVAX on 08/27/2015 with no complaints. Patient is a nurse and feels the PREVNAR 13 vaccine was given too high in the arm. She states vaccine was given within 1 inch of top of shoulder and thinks a nerve was hit. I am going to fill our a VAERS form concerning the incident. She does not require a follow-up call. She requested that administering pharmacist was made aware of incident and that he re-evaluated technique so this does not happen again.
no adverse reactions, administered expired vaccine. vaccine expired 10/29/22, administered 11/2/22
Patient states her eyes started itching and burning at approx. 10:30 a.m., 2 1/2 hours after flu shot was administered.  At 11:00 a.m., at the start of her lunch, she reported her throat tightening and was having trouble breathing. 911 was called and she was taken to ER.  The ER doctor dismissed the allergic reaction being caused by the flu vaccine.  However, the next day, patient was seen by her primary doctor and he told her the reaction was caused by the flu vaccine and told her to not receive the vaccine in the future. She reports her lunch was familiar foods and that she did not eat anything unusual. 11/13/08-records received for DOS 11/6/08-presented to PCP office day after vaccine and visit to ED. Two hours after receiving flu shot tongue was swelling and C/O SOB. Seen in ED examined and no treatment rendered. PE in PCP office normal. Assessment: Flu shot reaction.
Syncope and fall. Struck head on fall. Vomiting confusion after fall and transported to ER.
The right shoulder and arm pain so much and has tingling sensation at the same time. It interferes with my ability to work to make my living.
A few hours after the shot, I started becoming very tired and weak,  Body aches pains.  A bad severe headache.  I kept getting sharp stabbing pains on my upper left back all the next day after the shot.  I believe was my kidneys.  I have 3 kidneys, (NO typo, 3 kidneys) I have two half size kidneys on my left side.  I have had stones in past, but never sharp pain like this.   I missed work on Thursday.  Had no energy all day.  Slept wrapped in blanket.  I was constantly cold on Thursday.  My arm is sore with red spot and bump under skin.
pt recv vax 14NOV96 & immed p/vax pt devel hives;pt was treated w/sudafed;pt recovered from sx;
Almost immediately after the vaccination I had excessive and painful inflammation in both knees, both shoulders, my neck, pelvis, and back for 3 days. It felt as if it was contorting my body into a deformed ball. With no present injury to these sites prior to the injection it was pretty clear that this was targeting  issues I had had with these area in my past. It was inflammation pumped directly into those locations. Very painful. After 3 days I was back to normal.
They received the Pfizer/Biontech COVID vaccine and they are sick with COVID; They received the Pfizer/Biontech COVID vaccine and they are sick with COVID; This is a spontaneous report from a contactable consumer via Pfizer sales representative. This report was received via a sales representative.   A patient of unspecified age and gender received bnt162b2 (BNT162B2), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. It was reported that after receiving the pfizer/biontech covid vaccine the patient was sick with covid on an unspecified date. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date. The outcome of all the events were unknown.  No follow up attempts are possible. Information on Lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : -PFIZER INC-202101170074 same reporter/product/event, different patient
After patient received TD immunization (at 1:50 pm) she complained of shortness of breath, right side of throat felt tight and "jittery inside" blood pressure 120/98 administered BENADRYL 25mg intramuscular at 2pm and Epinephrine at 2:08 pm, oxygen at 2 liter/minute.  Post Epinephrine she began to feel better.  She left the clinic around 2:45.  Nurse practitioner called her around 3:30 and she said she felt fine. 08-03-2006 4;15 pm I called, she said she was fine, arm is sore.
vaccines being given post temperature excursion with no reported adverse event; Initial information received on 06-May-2022 regarding an unsolicited valid non-serious case received via other health professional.  This case involves a 7 years old male patient who experienced vaccines being given post temperature excursion with no reported adverse event while receiving vaccine influenza quadrival a-b vaccine [Fluzone QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Covid-19 Vaccine for Prophylactic vaccination.  On 02-May-2022, the patient received a dose of suspect influenza quadrival a-b vaccine at a dose of 0.5 ml with lot UT7376NA via intramuscular route in the left deltoid for Immunization.  On 02-May-2022 (latency: same day) the patient developed vaccines being given post temperature excursion with no reported adverse event (poor quality product administered) following the administration of influenza quadrival a-b vaccine.   Action taken: not applicable.  Outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  01092869: 01092879: 01092814: 01092832: 01092891: 01092687: 01092746: 01092709: 01092787: 01092803: 01092850:
STARTED WITH REDNESS TO THE AREA, GAVE BENADRYL LAST NIGHT.  WOKE UP THIS MORNING WITH A KNOT.